Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The metric has seen a significant loss of -79.46% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -76.44%. Over the past 30 days, the price of VOR has fallen by 34.62%. And in the last five days, it has surged by 16.09%.
The stock market performance of Vor Biopharma Inc has been fairly unsteady.
52-week price history of VOR Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Vor Biopharma Inc’s current trading price is -86.65% away from its 52-week high, while its distance from the 52-week low is 83.30%. The stock’s price range over this timeframe has been between $0.13 and $1.80. The shares of the Healthcare sector company recorded a trading volume of approximately 6.12 million for the day, which was comparatively higher than the average daily volume of 2.23 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Vor Biopharma Inc (VOR) has experienced a quarterly decline of -71.80% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 30.03M and boasts a workforce of 159 employees.
How Moving Averages and Trading Volume Data Work Together
VOR’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for VOR stands at 0.47. Similarly, the long-term debt-to-equity ratio is also 0.40.
